PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10736425-7	2000	Moreover, using IAAQ, we showed that molar excesses of chloroquine, quinine, quinidine, and MK-571 inhibit the photoaffinity labeling of MRP.	verlukast	92-98	ATP binding cassette subfamily C member 3	Homo sapiens	137-140	
7961706-9	1994	In addition, MK 571 preferentially inhibited photoaffinity labeling of the 190-kDa protein in the MRP transfectants.	verlukast	13-19	ATP binding cassette subfamily C member 3	Homo sapiens	98-101	
23994649-4	2013	The extracellular levels of PGE2, PGF2alpha, and TXB2 (a metabolite of TXA2) were decreased by treatment with MRP inhibitors (dipyridamole, MK571, and probenecid).	verlukast	140-145	ATP binding cassette subfamily C member 3	Homo sapiens	110-113	
19732815-4	2010	MK-571, a multidrug resistance associated protein (MRP) inhibitor, significantly suppressed DOX efflux from M5076 ovarian sarcoma cells.	verlukast	0-6	ATP binding cassette subfamily C member 3	Homo sapiens	10-49	
19732815-4	2010	MK-571, a multidrug resistance associated protein (MRP) inhibitor, significantly suppressed DOX efflux from M5076 ovarian sarcoma cells.	verlukast	0-6	ATP binding cassette subfamily C member 3	Homo sapiens	51-54	
15210835-4	2004	Calcein efflux was sensitive to temperature, energy depletion, and the MRP antagonist MK571 [3-[[3-[2-(7-chloroquinolin-2-yl)vinyl]phenyl]-(2-dimethylcarbamoylethylsulfanyl)methylsulfanyl] propionic acid].	verlukast	86-91	ATP binding cassette subfamily C member 3	Homo sapiens	71-74	
12048155-4	2002	BSO and MK-571, which inhibit the efflux of drugs mediated by multidrug resistance-associated protein (MRP), increased the action of both inhibitors, indicating that the latter enter the cells and that their export is mediated by MRP in both cell lines.	verlukast	8-14	ATP binding cassette subfamily C member 3	Homo sapiens	62-101	
12048155-4	2002	BSO and MK-571, which inhibit the efflux of drugs mediated by multidrug resistance-associated protein (MRP), increased the action of both inhibitors, indicating that the latter enter the cells and that their export is mediated by MRP in both cell lines.	verlukast	8-14	ATP binding cassette subfamily C member 3	Homo sapiens	103-106	
12048155-4	2002	BSO and MK-571, which inhibit the efflux of drugs mediated by multidrug resistance-associated protein (MRP), increased the action of both inhibitors, indicating that the latter enter the cells and that their export is mediated by MRP in both cell lines.	verlukast	8-14	ATP binding cassette subfamily C member 3	Homo sapiens	230-233	
22982073-8	2012	MK-571, chemical inhibitor of MRP2, MRP3, and MRP4, significantly reduced the efflux of glucuronide in the apical-to-basolateral (A-B) and B-A directions in a dose-dependent manner.	verlukast	0-6	ATP binding cassette subfamily C member 3	Homo sapiens	36-40	
18396325-3	2008	We quantified effects of PSC833, a specific inhibitor of mammalian P-gp (P-glycoprotein, ABCB1), and MK571, which blocks MRP (Multidrug resistance associated protein, ABCC) type transporters, on calcein-am efflux in gill tissue of Mytilus californianus.	verlukast	101-106	ATP binding cassette subfamily C member 3	Homo sapiens	121-124	
18396325-3	2008	We quantified effects of PSC833, a specific inhibitor of mammalian P-gp (P-glycoprotein, ABCB1), and MK571, which blocks MRP (Multidrug resistance associated protein, ABCC) type transporters, on calcein-am efflux in gill tissue of Mytilus californianus.	verlukast	101-106	ATP binding cassette subfamily C member 3	Homo sapiens	126-165	
17287390-9	2007	On the other hand, the intracellular resveratrol retention in cells treated with MK571 (3-[[3-[2-(7-chloroquinolin-2-yl)vinyl]phenyl]-(2-dimethylcarbamoylethylsulfanyl)methylsulfanyl] propionic acid), a multidrug resistance-associated protein inhibitor, strongly suggests the involvement of this ABC transporter family in the efflux of resveratrol conjugates from human liver.	verlukast	81-86	ATP binding cassette subfamily C member 3	Homo sapiens	203-242	
15793098-9	2005	This efflux was decreased by multidrug resistance-associated protein (MRP) inhibitors (probenecid, MK-571) and by ATP depletion.	verlukast	99-105	ATP binding cassette subfamily C member 3	Homo sapiens	29-68	
15793098-9	2005	This efflux was decreased by multidrug resistance-associated protein (MRP) inhibitors (probenecid, MK-571) and by ATP depletion.	verlukast	99-105	ATP binding cassette subfamily C member 3	Homo sapiens	70-73	
11212217-8	2001	Moreover, MK571, an inhibitor of MRP, significantly stimulated dye accumulation, whereas inhibitors of the multidrug resistance gene (MDR1) product Pglycoprotein, cyclosporin A and verapamil, did not.	verlukast	10-15	ATP binding cassette subfamily C member 3	Homo sapiens	33-36	
10421622-11	1999	Efflux of GS-MF was apparently inhibited by MK571, a specific inhibitor for MRP.	verlukast	44-49	ATP binding cassette subfamily C member 3	Homo sapiens	76-79